Source Feed: Global News - Canada
Author: Adriana Fallico
Publication Date: June 18, 2026 - 16:04
Stay informed
People on GLP-1 drugs appear to do less physical activity: study
June 18, 2026
Participants' daily steps decreased from about 5,047 to 4,487 per day. Moderate-to-vigorous physical activity also dropped, from 28 minutes a day to 22 minutes a day,
Unpublished Newswire
After several days of hot and sometimes threatening weather, it looks like the capital's in for a more pleasant break for the next few days. Read More
July 16, 2026 - 09:46 | Norman Provencher | Ottawa Citizen
Lecanemab is an antibody that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of the disease.
July 16, 2026 - 09:35 | Globalnews Digital | Global News - Canada
July 16, 2026 - 09:33 | Aaron Sousa | The Globe and Mail
Comments
Be the first to comment